Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 30,000 shares at $62.88 ($1.9M) on 2024-09-17, disclosed to the SEC on 2024-09-18.
Scheduled sale ($1.9M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.88 | 10,000 | $629K | 33.6% |
| 2 | $61.89 | 7,963 | $493K | 26.4% |
| 3 | $61.89 | 7,963 | $493K | 26.4% |
| 4 | $62.58 | 2,037 | $127K | 6.8% |
| 5 | $62.58 | 2,037 | $127K | 6.8% |
| Total | $62.31 avg | 30,000 |
| $1.9M |
| 100% |
| Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |
| HALO | SELL | 2024-06-20 | $494K | — | Filing → |